|
7th Thomas Ashworth CTC & Liquid Biopsy Symposium
2020 |
Key Dates
|
Registration opens: 1st June 2020 Earlybird registration closes: 11 September 2020 Final registration closes: 9 th October 2020 Symposium dates: 15 - 16 October 2020 |
#TAS2020
|
Welcome
|
On behalf of the organizing committee I invite you to attend the 7th Thomas Ashworth CTC & Liquid Biopsy Symposium 2020 to be held at the Aerial UTS Function Centre, Sydney, Australia. This elevated 7th floor space is a well-designed conference venue located in the vibrant UTS Ultimo precinct close to Central Railway Station. We hope it will inspire both speakers and attendees to engage enthusiastically in the liquid biopsy discussion.
The Symposium will run over 2 days enabling us to cover cutting-edge advances in liquid biopsy translational research and clinical practice. The program will begin at 9am on Thursday 15th October, with registration from 8.30am, and close at 5pm on Friday 16th October. The aim of the Symposium is to enrich our understanding of the clinical application of liquid biopsy to advance precision oncology and improve patient outcome, as well as provide critical insights into the metastatic process. An exciting line up of international speakers who are leaders in the field, along with national speakers from across Australia, will be showcasing their liquid biopsy research. Topics that will be explored include circulating tumour cells, exosomes, methylated ctDNA, assay development, early detection, integration of liquid biopsy into clinical trials and precision oncology, treatment selection and monitoring as well as drug resistance monitoring. This year we will again highlight the "Making an IMPACT" keynote presentation that will showcase research by an Australian researcher that will likely achieve a high clinical impact and be translated into routine practice. Poster presentations are invited from delegates and to encourage students and early career researchers, a Young Investigator Rapid-fire talks (selected from submitted poster abstracts) is integrated into the program. Generous awards will be given for the best young investigator poster and Rapid-fire talks - so please submit an abstract. This is a great opportunity. Who should attend?
The organising committee maintains a philosophy of keeping registration costs as low as possible to encourage attendance and this is only possible due to the generous support of our sponsors. So please ensure to visit the exhibitor tables and check out their latest product offerings. We look forward to seeing you at the Symposium in October. Associate Professor Kevin Spring Convenor, 7th Thomas Ashworth CTC & Liquid Biopsy Symposium 
|
International and National Keynote Speakers
|
Associate Professor Scott Kopetz, MD PhD University of Texas and MD Anderson Cancer Center, Houston, USA |
|
Professor Raghu Kalluri, MD, PhD University of Texas and MD Anderson Cancer Center, Houston, USA |
|
Dr Cloud Paweletz, PhD Head Translational Research Laboratory, Dana-Farber Cancer Institute, USA |
|
Professor Helen Rizos, PhD Macquarie University, Sydney Australia |
|
Platinum Sponsors
|
|
Gold Sponsors
|
|
|
Supporting Sponsor
Organizing Committee
A/Prof. Kevin Spring ( Convenor), Ingham Institute, Western Sydney University, Sydney
Prof. Paul de Souza, University of Wollongong, Wollongong
A/Prof. Therese Becker, Ingham Institute, Sydney
Dr. Mark Cowley, Children's Cancer Institute, Sydney
A/Prof Alex Dobrovic, Oliver Newton-John Cancer Research Institute, Melbourne
Dr Stephen Wong, Peter MacCallum Cancer Centre, Melbourne
Dr. Craig Gedye, Calvary Mater Newcastle & Hunter Medical Research Institute, University of Newcastle, Newcastle
A/Prof Chamindie Punyadeera, QUT, Brisbane
Dr. Katie Meehan, University of Western Australia, Perth
Prof. Rik Thompson, QUT, Brisbane
For more information please contact A/Prof Kevin Spring - k.spring@westernsydney.edu.au
Host Institutions
|
|
|
|